Kura Oncology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kura Oncology and other ETFs, options, and stocks.

About KURA

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias.

CEO

Troy E. Wilson

CEOTroy E. Wilson

Employees

260

Employees260

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2014

Founded2014

Employees

260

Employees260

KURA Key Statistics

Market cap

1.06B

Market cap1.06B

Price-Earnings ratio

-3.54

Price-Earnings ratio-3.54

Dividend yield

—

Dividend yield—

Average volume

2.45M

Average volume2.45M

High today

$12.22

High today$12.22

Low today

$11.67

Low today$11.67

Open price

$11.78

Open price$11.78

Volume

2.03M

Volume2.03M

52 Week high

$12.90

52 Week high$12.90

52 Week low

$7.36

52 Week low$7.36

Stock Snapshot

As of today, Kura Oncology(KURA) shares are valued at $11.90. The company's market cap stands at 1.06B, with a P/E ratio of -3.54.

During the trading session on 2026-08-22, Kura Oncology(KURA) shares reached a daily high of $12.22 and a low of $11.67. At a current price of $11.90, the stock is +2.0% higher than the low and still -2.6% under the high.

Trading activity shows a volume of 2.03M, compared to an average daily volume of 2.45M.

Over the past 52 weeks, Kura Oncology(KURA) stock has traded between a high of $12.90 and a low of $7.36.

KURA News

Simply Wall St 21h

Why Kura Oncology Is Up 9.5% After New Menin Inhibitor Data And Q2 Results - simplywall.st

...

Nasdaq 3d

Kura Oncology Q2 2026 Earnings Call Transcript

Kura Oncology (KURA) Q2 2026 Earnings Call Transcript The Motley Fool Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is...

Simply Wall St 4d

Troy Wilson Bought 12% More Shares In Kura Oncology

Kura Oncology, Inc. ( ) shareholders (or potential shareholders) will be happy to see that the Chairman, Troy Wilson, recently bought a whopping US$1.1m worth o...

Analyst ratings

93%

of 15 ratings

Buy

93.3%

Hold

6.7%

Sell

More KURA News

TipRanks 5d

Top Executive Makes Bold Insider Move at Kura Oncology

New insider activity at Kura Oncology ( (KURA) ) has taken place on August 17, 2026. Summer Sale - Claim 70% Off TipRanks Unlock powerful investing tools with T...

TipRanks 5d

Kura Oncology CEO buys $1.11M in common stock

In a regulatory filing, Kura Oncology (KURA) disclosed that its CEO Troy Wilson bought 100K shares of common stock on August 17th in a total transaction size of...

People also own

Based on the portfolios of people who own KURA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.